Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |